Nephrogenic systemic fibrosis and gadolinium-based contrast agents.

Nephrogenic systemic fibrosis and gadolinium-based contrast agents.

Item
http://www.wikidata.org/entity/Q34181301
Manganese-based MRI contrast agents: past, present and future.Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods.Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.Diagnostic utility of diffusion-weighted magnetic resonance imaging in two common renal tumorsEADC Values in Diagnosis of Renal Lesions by 3.0 T Diffusion-Weighted Magnetic Resonance Imaging: Compared with the ADC ValuesPediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.Ultrasound in gynecological cancer: is it time for re-evaluation of its uses?Imaging patients with renal impairment.In vivo magnetic resonance imaging of glucose - initial experience.Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.Diagnostic imaging in the management of patients with metabolic syndrome.Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.Application of spin-crossover water soluble nanoparticles for use as MRI contrast agents
P2860

Nephrogenic systemic fibrosis and gadolinium-based contrast agents.

Item
http://www.wikidata.org/entity/Q34181301
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@ast
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@en
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@nl
type
label
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@ast
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@en
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@nl
prefLabel
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@ast
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@en
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
@en
P2093
P304
P31
P356
10.1053/J.ACKD.2011.03.001
P433
P478
P577
P698